Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 119 (4) , 903-908
- https://doi.org/10.1053/gast.2000.18159
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanismGut, 2000
- Heparin, cell adhesion, and pathogenesis of inflammatory bow el diseaseThe Lancet, 1999
- Unfractioned Heparin in The Therapy of Patients With Highly Active Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 1999
- Arg506Gln Factor V Mutation and Val34Leu Factor XIII Polymorphism in Finnish Patients with Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1999
- The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel diseaseGastroenterology, 1998
- Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging studyGastroenterology, 1998
- Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.Journal of Clinical Investigation, 1998
- Treatment of corticosteroid‐resistant ulcerative colitis with heparin —a report of 16 casesAlimentary Pharmacology & Therapeutics, 1997
- 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.Gut, 1995
- Mucosal capillary thrombi in rectal biopsiesHistopathology, 1992